Financial statements Europharma Alliance

Balance sheet of Europharma Alliance

Company age:
Age:
18 y. 4 m. 10 d.
Share capital:
Share capital:
200 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of EUROPHARMA ALLIANCE

Year
2018
2019
2020
2021
2022
2023
Total assets 24 094 069,11 25 728 480,33 30 536 398,93 34 047 664,39 42 749 648,66 45 407 288,99
A. Fixed assets 12 542 998,82 12 183 175,09 14 229 867,45 18 085 564,44 23 535 508,34 21 280 363,52
B. Current assets 11 551 070,29 13 545 305,24 16 306 531,48 15 962 099,95 19 214 140,32 24 126 925,47
C. Share capital contributions (basic funds) - - 0,00 0,00 0,00 0,00
D. Own shares (stocks) - - 0,00 0,00 0,00 0,00
Total liabilities 24 094 069,11 25 728 480,33 30 536 398,93 34 047 664,39 42 749 648,66 45 407 288,99
A. Equity 15 979 478,00 18 734 876,91 24 733 666,51 30 628 733,86 33 717 924,76 37 981 657,72
B. Liabilities and provisions for liabilities 8 114 591,11 6 993 603,42 5 802 732,42 3 418 930,53 9 031 723,90 7 425 631,27
I. Long-term liabilities 3 485 002,74 440 128,20 353 253,45 181 998,84 2 720 340,88 1 751 231,72
II. Short-term liabilities 4 315 952,46 6 553 475,22 5 175 050,05 2 998 999,14 5 783 618,37 5 339 436,50
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.